Literature DB >> 21322086

Comparing costs and outcomes across programmes of health care.

Stephen Martin1, Nigel Rice, Peter C Smith.   

Abstract

This paper examines the expenditure choices of local health authorities operating under fixed budget constraints. It applies a theoretical model of budgeting to a data set from 303 English Primary Care Trusts (PCTs) across ten broad programmes of health care to derive estimates of the elasticity of expenditure in each programme with respect to the total income of the PCT. The results suggest quite similar income elasticities across most programmes, in the range 0.644-1.128. The only outlier is the musculoskeletal programme with an elasticity of about 0.46. The modelling also derives estimates of spending elasticities with respect to medical needs and thereby permits calculation of the implicit cost of saving a life year in five programmes of care. The results are important as they indicate to policy makers how specific programme areas might be affected by general budgetary reductions.
Copyright © 2011 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Year:  2011        PMID: 21322086     DOI: 10.1002/hec.1716

Source DB:  PubMed          Journal:  Health Econ        ISSN: 1057-9230            Impact factor:   3.046


  12 in total

1.  NICE's cost-effectiveness range: should it be lowered?

Authors:  J P Raftery
Journal:  Pharmacoeconomics       Date:  2014-07       Impact factor: 4.981

2.  Estimating the Reference Incremental Cost-Effectiveness Ratio for the Australian Health System.

Authors:  Laura Catherine Edney; Hossein Haji Ali Afzali; Terence Chai Cheng; Jonathan Karnon
Journal:  Pharmacoeconomics       Date:  2018-02       Impact factor: 4.981

Review 3.  Association Between Spending and Outcomes for Patients With Cancer.

Authors:  Meng Li; Darius N Lakdawalla; Dana P Goldman
Journal:  J Clin Oncol       Date:  2019-12-05       Impact factor: 44.544

4.  Application of patient-reported outcome measures (PROMs) data to estimate cost-effectiveness of hernia surgery in England.

Authors:  Sophie Coronini-Cronberg; John Appleby; James Thompson
Journal:  J R Soc Med       Date:  2013-05-28       Impact factor: 5.344

5.  Population health needs assessment and healthcare services use in a 3 years follow-up on administrative and clinical data: results from the Brisighella Heart Study.

Authors:  Arrigo F G Cicero; Martina Rosticci; Sergio D'Addato; Cristina Baronio; Giulia Grossi; Elisa Grandi; Claudio Borghi
Journal:  High Blood Press Cardiovasc Prev       Date:  2013-11-16

6.  Cost-Effectiveness of Cetuximab for Advanced Esophageal Squamous Cell Carcinoma.

Authors:  Vincent T Janmaat; Marco J Bruno; Suzanne Polinder; Sylvie Lorenzen; Florian Lordick; Maikel P Peppelenbosch; Manon C W Spaander
Journal:  PLoS One       Date:  2016-04-21       Impact factor: 3.240

7.  Country-Level Cost-Effectiveness Thresholds: Initial Estimates and the Need for Further Research.

Authors:  Beth Woods; Paul Revill; Mark Sculpher; Karl Claxton
Journal:  Value Health       Date:  2016-12       Impact factor: 5.725

8.  Health Opportunity Costs: Assessing the Implications of Uncertainty Using Elicitation Methods with Experts.

Authors:  Marta O Soares; Mark J Sculpher; Karl Claxton
Journal:  Med Decis Making       Date:  2020-05-22       Impact factor: 2.583

9.  Death by austerity? The impact of cost containment on avoidable mortality in Italy.

Authors:  Emanuele Arcà; Francesco Principe; Eddy Van Doorslaer
Journal:  Health Econ       Date:  2020-08-17       Impact factor: 3.046

10.  The Relevance of Including Future Healthcare Costs in Cost-Effectiveness Threshold Calculations for the UK NHS.

Authors:  Megan Perry-Duxbury; James Lomas; Miqdad Asaria; Pieter van Baal
Journal:  Pharmacoeconomics       Date:  2021-10-26       Impact factor: 4.981

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.